Legend Bio's CEO Placed on House Arrest after China Investigation

Legend Biotech of Nanjing announced its CEO, Dr. Fangliang Zhang, is under China house arrest, presumably because of alleged violations of China import and export regulations. Officials from China Customs Office appeared in Legend's offices on Friday, September 18 to conduct an inspection. Fierce Biotech believes authorities were most likely looking for violations of China's tightened rules for export of human genetic resources or import of plasma products. Legend's lead candidate is a BCMA-targeted CAR-T cell therapy that it partnered with Janssen in a $1 billion deal. More details.... Stock Symbol: (NSDQ: LEGN) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.